Key points are not available for this paper at this time.
Individuals living in the US with hematologic, head and neck, and lung cancers had a 9-fold higher rate of developing active TB compared to those without cancer and would benefit from targeted latent TB screening and therapy.
Cheng et al. (Thu,) studied this question.